Productos Medix SA de CV:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Productos Medix SA de CV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11181
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:メキシコ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Productos Medix SA de CV (Medix), formerly Laboratories Laif is a provider of research, development, manufacturing and marketing of pharmaceutical chemical products. The company’s products comprise livermade, pylopac, imidex, seronex, feprorex, MZ1, redotex, terfamex, prepram,sinestron, antalgin, biolaif and dixoal, among others. Its products are used to improve the proper functioning of the organism in patients with deficiencies caused by diseases such as diabetes, obesity, and metabolic syndrome, among others. The company’s dialicels allows more effective drug dosage. It markets its products in Mexico and abroad. Medix is headquartered in Coyoacan, Mexico.

Productos Medix SA de CV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Productos Medix SA de CV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Wamex Private Equity Invests US$32 Million In Productos Medix 10
Partnerships 11
Saniona Enters into Agreement with Productos Medix 11
Licensing Agreements 12
KVK-Tech Enters into Licensing Agreement with Productos Medix 12
Medifast Enters Into Licensing Agreement With Productos Medix 13
Medifast Enters Into Licensing Agreement With Productos Medix 14
Productos Medix SA de CV – Key Competitors 15
Productos Medix SA de CV – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Key Facts 2
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Productos Medix SA de CV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Productos Medix SA de CV, Deals By Therapy Area, 2012 to YTD 2018 8
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Wamex Private Equity Invests US$32 Million In Productos Medix 10
Saniona Enters into Agreement with Productos Medix 11
KVK-Tech Enters into Licensing Agreement with Productos Medix 12
Medifast Enters Into Licensing Agreement With Productos Medix 13
Medifast Enters Into Licensing Agreement With Productos Medix 14
Productos Medix SA de CV, Key Competitors 15

List of Figures
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Productos Medix SA de CV:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • C. Uyemura & Co., Ltd. (4966):企業の財務・戦略的SWOT分析
    C. Uyemura & Co., Ltd. (4966) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Avista Corporation
    Avista Corporation - Strategy, SWOT and Corporate Finance Report Summary Avista Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ellex Medical Lasers Limited (ELX):企業の財務・戦略的SWOT分析
    Ellex Medical Lasers Limited (ELX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Anavex Life Sciences Corp (AVXL):企業の財務・戦略的SWOT分析
    Anavex Life Sciences Corp (AVXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • IntelliCell BioSciences Inc:企業の戦略的SWOT分析
    IntelliCell BioSciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Bank Of Ireland (Uk) Plc:企業の戦略・SWOT・財務分析
    Bank Of Ireland (Uk) Plc - Strategy, SWOT and Corporate Finance Report Summary Bank Of Ireland (Uk) Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Vita 34 AG (V3V):製薬・医療:M&Aディール及び事業提携情報
    Summary Vita 34 AG (Vita 34), formerly Vita 34 International AG, is an umbilical cord blood bank that collects, prepares, processes, deposits, and stores stem cells from umbilical cord blood. The company's products comprise vitaplus, vitaplus25, vitaplus50, vitapluscordtissue, vitapluscordtissue25, …
  • Fusion Telecommunications International, Inc.:企業のM&A・事業提携・投資動向
    Fusion Telecommunications International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fusion Telecommunications International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, …
  • McLean Electric Cooperative Inc:企業の戦略的SWOT分析
    McLean Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • TIVIT Terceirizacao de Tecnologia e Servicos SA:企業の戦略的SWOT分析
    TIVIT Terceirizacao de Tecnologia e Servicos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Newfoundland Power Inc.:企業の戦略的SWOT分析
    Newfoundland Power Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • M1 Ltd (B2F):企業の財務・戦略的SWOT分析
    M1 Ltd (B2F) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • University of California San Diego-医療機器分野:企業M&A・提携分析
    Summary University of California San Diego (UCSD), a subsidiary of University of California, is a public research university that offers education and research with a portfolio of undergraduate, graduate, postdoctoral and professional schools. It offers courses in various fields including arts and h …
  • QuadraMed Corp-医療機器分野:企業M&A・提携分析
    Summary Quadramed Corporation (Quadramed) is a healthcare technologies and service provider. It provides solutions to various healthcare organizations to improve the safety, efficiency and quality of patient care. The company's solutions enable its clients in streamlining processes, increase product …
  • Societe Tunisienne de l’Electricite et du Gaz:企業の戦略的SWOT分析
    Societe Tunisienne de l'Electricite et du Gaz - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Emera Inc.:戦略・SWOT・企業財務分析
    Emera Inc. - Strategy, SWOT and Corporate Finance Report Summary Emera Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Broadridge Financial Solutions, Inc.:企業のM&A・事業提携・投資動向
    Broadridge Financial Solutions, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Broadridge Financial Solutions, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Enterprise Ireland:医療機器:M&Aディール及び事業提携情報
    Summary Enterprise Ireland (EI) is an economic development organization that offers enterprise development programs. The organization’s activities include funding supports, export assistance, supports to develop competitiveness, incentives to stimulate in-company research and development, assistance …
  • Castle Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Castle Biosciences Inc (Castle Biosciences) is a drug development company that develops and commercializes diagnostic and prognostic tests for cancers. The company offers tests for cutaneous melanoma, uveal melanoma and glioblastoma multiforme. Its DecisionDx-melanoma identifies stage I or I …
  • New Age (African Global Energy) Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary New Age (African Global Energy) Ltd (New Age) is an oil and gas company that explores and develops oil and gas fields, and oil wells. The company provides activities such as include exploration, production, appraisal and development of oil and gas assets in seven sub Saharan African countrie …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆